[HTML][HTML] Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases

U Sengupta, R Kayed - Progress in neurobiology, 2022 - Elsevier
Aggregation of specific proteins are histopathological hallmarks of several
neurodegenerative diseases, such as, Amyloid β (Aβ) plaques and tau neurofibrillary …

Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease

SP Yu, MQ Jiang, SS Shim, S Pourkhodadad… - Molecular …, 2023 - Springer
Stroke and late-onset Alzheimer's disease (AD) are risk factors for each other; the
comorbidity of these brain disorders in aging individuals represents a significant challenge …

[HTML][HTML] Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling

E Kim, H Kim, MP Jedrychowski, G Bakiasi, J Park… - Neuron, 2023 - cell.com
A pathological hallmark of Alzheimer's disease (AD) is the deposition of amyloid-β (Aβ)
protein in the brain. Physical exercise has been shown to reduce Aβ burden in various AD …

Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression

S Meftah, J Gan - Frontiers in Synaptic Neuroscience, 2023 - frontiersin.org
The synapse has consistently been considered a vulnerable and critical target within
Alzheimer's disease, and synapse loss is, to date, one of the main biological correlates of …

Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease

AI Wiesman, DL Murman, RA Losh, M Schantell… - Brain, 2022 - academic.oup.com
An extensive electrophysiological literature has proposed a pathological 'slowing'of
neuronal activity in patients on the Alzheimer's disease spectrum. Supported by numerous …

Sensory processing deficits and related cortical pathological changes in Alzheimer's disease

NK Zhang, SK Zhang, LI Zhang, HW Tao… - Frontiers in Aging …, 2023 - frontiersin.org
Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily affecting
cognitive functions. However, sensory deficits in AD start to draw attention due to their high …

[HTML][HTML] An electrochemical sensing platform based on gold nanostars for the detection of Alzheimer's disease marker Aβ oligomers (Aβo)

P Wang, S Chen, Y Guan, Y Li, A Jiamali - Alexandria Engineering Journal, 2023 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the
accumulation of amyloid-beta (Aβ) peptides in the brain. Among the different forms of Aβ …

Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer's disease

DI Sideris, JSH Danial, D Emin, FS Ruggeri… - Brain …, 2021 - academic.oup.com
Protein aggregation likely plays a key role in the initiation and spreading of Alzheimer's
disease pathology through the brain. Soluble aggregates of amyloid beta are believed to …

Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities

S Li, AM Stern - Molecular Psychiatry, 2022 - nature.com
The accumulation of amyloid-β protein (Aβ) plays an early role in the pathogenesis of
Alzheimer's disease (AD). The precise mechanism of how Aβ accumulation leads to synaptic …

[HTML][HTML] Noradrenergic neuromodulation in ageing and disease

F Krohn, E Lancini, M Ludwig, M Leiman… - Neuroscience & …, 2023 - Elsevier
The locus coeruleus (LC) is a small brainstem structure located in the lower pons and is the
main source of noradrenaline (NA) in the brain. Via its phasic and tonic firing, it modulates …